Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Pramlintide

A Study To Examine The Efficacy And Safety Of Pramlintide+Metreleptin In Obese Subjects

AstraZeneca · Phase 2 · Terminated · Enrollment 213

NCT01235741

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Group An/rn/rn/rn/rn/r
Group Bn/rn/rn/rn/rn/r
Placebo1 participantsn/rn/rn/rn/r
Pramlintide + Metreleptin7 participantsn/rn/rn/rn/r

A count stays a count. This page does not turn a count into a percent.